Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 5736 of 5804
-
Healthy men needed to test experimental Drug's safety
Knowledge-focused Recruiting nowThis is a randomized, double-blind, first-in-human study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of single and multiple oral doses of YH35995
Phase: PHASE1 • Sponsor: Yuhan Corporation • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC
-
Coffee warning for nail fungus patients?
Knowledge-focused ENROLLING_BY_INVITATIONThe investigators hypothesize that there would be significant changes in blood pressure or heart rate in patients consuming caffeine while taking terbinafine.
Phase: NA • Sponsor: Weill Medical College of Cornell University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC
-
Wireless heart monitor for infants tested, but study ends early
Knowledge-focused TerminatedThe overall goal of this study is to understand the feasibility of using a wireless sensor device (instead of a wired device) to collect information used to monitor children with heart conditions at home.
Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:56 UTC
-
New drug ICP-332 tested for safety in small early study
Knowledge-focused CompletedA multiple ascending dose phase I study of ICP-332 in healthy subjects
Phase: PHASE1 • Sponsor: InnoCare Pharma Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC
-
Capsule vs tablet: which form of HRS-5965 works best?
Knowledge-focused CompletedThe study is designed as a single-center, randomized, open-label, cross-over phase I clinical trial with the intention of recruiting 16 healthy subjects.
Phase: PHASE1 • Sponsor: Chengdu Suncadia Medicine Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC
-
New antibody IMP761 tested for safety in healthy volunteers
Knowledge-focused Recruiting nowThe goal of this clinical trial is to evaluate the safety and tolerability of single and multiple doses of IMP761 in healthy female and male volunteers aged 18-55 with no history of disease affecting the immune system or recent use of medication with effects on the immune system.…
Phase: PHASE1 • Sponsor: Immutep S.A.S. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Pregnancy OMT study halted early – too few volunteers
Knowledge-focused TerminatedOsteopathic Manipulative Therapy (OMT) is a hands-on approach to treating conditions that affect all areas of the body. Physicians trained in OMT (Doctors of Osteopathic Medicine or DO) use OMT to correct structural imbalances in the body, relieve pain, and improve circulation. R…
Sponsor: Corewell Health South • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC
-
New drug combo aimed at helping smokers with schizophrenia
Disease control TerminatedThe purpose of this study is to assess the feasibility and safety of injectable naltrexone (NTX;380 mg) in conjunction with oral bupropion (BUP; 450 mg daily)NTX-BUP administration among individuals with schizophrenia spectrum disorders that smoke cigarettes and to evaluate chang…
Phase: PHASE1 • Sponsor: The University of Texas Health Science Center, Houston • Aim: Disease control
Last updated Jun 26, 2026 18:38 UTC
-
Can a web app accurately measure your breathing?
Knowledge-focused CompletedEvaluating the Accuracy of a Web-Based Application - Vital Sign Measurement Platform. This single-arm cohort, open-label study is designed to evaluate the accuracy of a web-based application designed for measurements of vital signs including respiratory rate (RR). The purpose of …
Sponsor: Mindset Medical • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
Healthy donors needed for research sample bank
Knowledge-focused Recruiting nowBackground: Laboratory tests that use blood and urine can provide a great deal of information about human health and disease. To develop even better tests and to improve the ways samples are handled for testing researchers need to experiment with samples from healthy people. Ob…
Sponsor: National Institute of Environmental Health Sciences (NIEHS) • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
Promising brain tumor treatment study halted before it began
Disease control TerminatedThe goal of this clinical trial is to assess the safety, toxicity, and antitumor activity of fourth ventricular infusions of nivolumab plus 5-azacytidine for recurrent ependymoma and nivolumab plus methotrexate for recurrent medulloblastoma and other CNS malignancies. Additional…
Phase: PHASE1 • Sponsor: Jeffrey Treiber • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New inhaled drug tested in healthy volunteers – no treatment expected
Knowledge-focused CompletedThe purpose of this study is to investigate the safety, tolerability, and pharmacokinetics (PK) of AZD4604 when administered as single or multiple inhaled doses to healthy Japanese and Chinese participants.
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC
-
Diabetes drug cocktail tested in healthy volunteers
Knowledge-focused CompletedThis study was designed as a single-center, single-arm, open, fixed-sequence, self-controlled trial in healthy subjects.
Phase: PHASE1 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Yale study tests if a pep talk boosts depression drug – but only one person joined
Knowledge-focused TerminatedThe investigators aim to examine the magnitude of non-specific effects in the treatment of depressive episodes with esketamine, by providing patients in the intervention group with a pretreatment presentation and post-treatment follow up session, to assess whether nonspecific eff…
Phase: NA • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC
-
New drug TML-6 tested for safety in healthy adults
Knowledge-focused CompletedThe purpose of this study is to evaluate the safety, tolerability, single-ascending dose (SAD), multiple-ascending dose (MAD), food effect, and pharmacokinetic (PK) Study of TML-6.
Phase: PHASE1 • Sponsor: Merry Life Biomedical Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:56 UTC
-
Brain stent blood thinner study pulled before it began
Disease control TerminatedThis study is a prospective, multicenter, open-label, randomized controlled clinical trial, aims to assess the clinical non-inferiority of 3 months (short-term) vs 6 months (long-term) of Dual Anti-Platelet Therapy (DAPT) in patients after implanted NOVA intracranial sirolimus-el…
Phase: NA • Sponsor: Sino Medical Sciences Technology Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Magne-B6 gets a makeover: new tablet tested against old liquid
Knowledge-focused CompletedThe purpose of the study is to assess the relative bioavailability of two Magne-B6 preparations, in fasting conditions.
Phase: PHASE1 • Sponsor: Opella Healthcare Group SAS, a Sanofi Company • Aim: Knowledge-focused
Last updated Jun 26, 2026 16:53 UTC
-
Healthy volunteers help test new imaging agent
Knowledge-focused CompletedThis is a Phase 1, single-center, open-label, single-arm, dose-escalation positron emission tomography study to assess the safety and tolerability, immunogenicity, Pharmacokinetics, dosimetry, and biodistribution after GEH200521 (18F) Injection is co-administered with GEH200520 I…
Phase: PHASE1 • Sponsor: GE Healthcare • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC
-
Massage meets engineering: tensegrity principle tested on healthy muscles
Knowledge-focused CompletedThe study design is a randomised, controlled, parallel, two-arm trial. The subjects are randomly assigned to one of the study groups: the intervention group or the control group. The study will analyze the applicability of the tensegrity principle in the massage therapy. The main…
Phase: NA • Sponsor: Wroclaw University of Health and Sport Sciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Promising cancer drug trial pulled before it even started
Disease control TerminatedTo learn if ASTX727 given alone or in combination with donor lymphocyte infusion (DLI) can help to control certain types of hematological neoplasms (blood-based cancers) after a stem cell transplant.
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC